These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6467768)

  • 1. Rapid prediction of individual dosage requirements for lignocaine.
    Vozeh S; Berger M; Wenk M; Ritz R; Follath F
    Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study for validation of Bayesian prediction approach to adjust individual lidocaine dosage.
    Uematsu T; Hirayama H; Umemura K; Kosuge K; Nakashima M
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):33-7. PubMed ID: 8199750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of individual dosage requirements for lignocaine: a validation study for Bayesian forecasting in Japanese patients.
    Uematsu T; Hirayama H; Nagashima S; Yamazaki T; Tsuchiya N; Sato R; Nakashima M
    Ther Drug Monit; 1989; 11(1):25-31. PubMed ID: 2911849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.
    Vozeh S; Uematsu T; Hauf GF; Follath F
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):203-12. PubMed ID: 4057058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for maintaining serum lidocaine levels in the therapeutic range.
    Wong BY; Hurwitz A
    Arch Intern Med; 1985 Sep; 145(9):1588-91. PubMed ID: 4026487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous lignocaine for chronic pain: an 18-month experience].
    Cahana A; Shvelzon V; Dolberg O; Magora F; Shir Y
    Harefuah; 1998 May; 134(9):692-4, 751, 750. PubMed ID: 10909615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lignocaine in the treatment of arrhythmia].
    Gürtler-Krawczyńska E
    Wiad Lek; 1971 Jun; 24(12):1205-9. PubMed ID: 5561278
    [No Abstract]   [Full Text] [Related]  

  • 15. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignocaine: a new technique for intravenous administration.
    Levy RA; Charuzi Y; Mandel WJ
    Br Heart J; 1977 Sep; 39(9):1026-8. PubMed ID: 907767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted drug assay interpretation based on Bayesian estimation of individual pharmacokinetics: application to lidocaine.
    Vozeh S; Hillman R; Wandell M; Ludden T; Sheiner L
    Ther Drug Monit; 1985; 7(1):66-73. PubMed ID: 3838832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance.
    Vozeh S; Uematsu T; Ritz R; Schmidlin O; Kaufman G; Scholer A; Follath F
    Am Heart J; 1987 Apr; 113(4):928-33. PubMed ID: 3565242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.